Refractive correction and patching improve VA in amblyopia

Article

Refractive correction and patching improves visual acuity in amblyopic eyes.

Refractive correction and patching improves visual acuity in amblyopic eyes, according to a paper in the Archives of Ophthalmology.

Dr Yi Pang et al., Illinois College of Optometry, Chicago, Illinois, USA, looked at 17 amblyopic children. The patients were aged between 4 and 14 years and has amblyopia linked to myopic anisometropia.

Visual acuity (VA) was evaluated at 4, 8, 12 and 16 weeks whilst all patients wore spectacles and/or contact lenses for complete refractive correction. At 16 weeks all patients underwent patching.

Mean baseline VA in amblyopic eyes improved from 0.96 logMAR to 0.84 logMAR with refractive correction and a mean of 0.71 logMAR with additional patching. The findings demonstrated an improvement of 2.59 lines when comparing baseline VA and final VA.

Final VA was linked to baseline VA, magnitude of anisometropia and the patching compliance level. The improvement in VA was linked to patient age and presence of eccentric fixation.

Overall, 88% of patients experienced an improvement of 2 lines or more and a further improvement was discovered when patching was applied to patients who underwent refractive correction.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.